Modern Synthesis Secures £5.5M to Pioneer a Sustainable, Plastic-Free Future in Fashion and Beyond

Modern Synthesis, a pioneering London-based biotech company, is thrilled to announce the successful closing of a funding round that raised £5,500,000, marking a transformative milestone in our journey to revolutionize material science.

With this investment, our dedicated team will accelerate efforts in harnessing the power of bacteria to create a groundbreaking class of nanocellulose-based materials.

These innovative materials are not only designed to provide the performance typically associated with plastics but also bring visually compelling aesthetics without relying on any animal-derived inputs.

This unique approach reflects our commitment to driving sustainable and ethical solutions for modern industries, starting with fashion and expanding well beyond.

The new funds will be strategically allocated to scale up our research and development initiatives, refining our fermentation and material synthesis processes to increase yield and efficiency.

Additionally, we plan to strengthen our partnerships within the fashion and design sectors, paving the way for wider adoption of our eco-friendly alternatives that address environmental challenges while meeting consumer demands for high-quality products.

This infusion of capital reinforces investor confidence in our mission to redefine how materials are sourced and manufactured, paving the path toward a future where performance, sustainability, and style coexist harmoniously.

As we embark on this exciting phase of growth, Modern Synthesis remains steadfast in its commitment to innovation and environmental stewardship, ensuring that each step we take brings us closer to a world powered by smarter, cleaner, and more responsible materials.